CrossrefInfokarte
Assessing the Efficacy and Safety of Dapagliflozin and Empgliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type-2 Diabetes Mellitus Patients
RUHS Journal of Health Science · 2025
DOI: 10.37821/ruhsjhs.10.2.2025.783 ↗Abstract
Kein Abstract verfügbar.
EUVIMED